
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.670 | 2.670 | 0.000 |
Shares | 97.330 | 97.330 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 32.982 | 34.495 |
Price to Book | 4.914 | 5.006 |
Price to Sales | 4.902 | 5.004 |
Price to Cash Flow | 12.293 | 23.656 |
Dividend Yield | 0.704 | 0.655 |
5 Years Earnings Growth | 17.516 | 14.104 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.980 | 96.226 |
Basic Materials | 1.020 | 4.978 |
Number of long holdings: 43
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 10.44 | 1,727.50 | +2.67% | |
Cipla | INE059A01026 | 5.52 | 1,490.90 | +0.46% | |
Dr Reddy’s Laboratories | INE089A01031 | 4.66 | 1,260.90 | +0.82% | |
Procter & Gamble Health | INE199A01012 | 4.34 | 5,859.00 | +0.74% | |
Ajanta Pharma Ltd | INE031B01049 | 4.09 | 2,697.70 | +1.94% | |
Glenmark Pharma | INE935A01035 | 3.78 | 2,226.10 | +0.31% | |
Apollo Hospitals | INE437A01024 | 3.65 | 7,360.50 | +1.95% | |
Divi's Labs | INE361B01024 | 3.49 | 6,790.00 | +0.17% | |
Fortis Healthcare | INE061F01013 | 3.09 | 799.25 | +2.17% | |
Eris Lifesciences | INE406M01024 | 3.04 | 1,754.30 | +0.45% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UTI Equity Fund Growth Option D | 254.34B | 4.20 | 16.59 | 13.21 | ||
UTI Equity Fund Income Option D | 254.34B | 4.20 | 16.56 | 13.09 | ||
UTI Equity Fund Growth | 254.34B | 3.88 | 15.74 | 12.51 | ||
UTI Equity Fund Dividend Payout | 254.34B | 3.88 | 15.71 | 12.38 | ||
UTI Master Share Growth Option Dire | 127.2B | 6.92 | 18.19 | 12.91 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review